# An AI-Based CDSS for Integrated Management of Patients With Acute Ischemic Stroke(GOLDEN BRIDGE II)

Study · id `cardio:ct-nct04524624` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04524624](<https://clinicaltrials.gov/study/NCT04524624>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04524624

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 21689 participants.

## Technical summary

Registry record NCT04524624. Randomized; single masking; primary purpose prevention. Start 2020-09-01 (anticipated); primary completion 2022-09-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 21689 participants (planned count; ClinicalTrials.gov record NCT04524624, source copy `cardio:ctgov-nct04524624-2020-08-24`, retrieved 2026-10-26)
- Planned start: 2020-09-01 (anticipated) (ClinicalTrials.gov record NCT04524624, source copy `cardio:ctgov-nct04524624-2020-08-24`, retrieved 2026-10-26)
- Primary completion: 2022-09-30 (anticipated) (ClinicalTrials.gov record NCT04524624, source copy `cardio:ctgov-nct04524624-2020-08-24`, retrieved 2026-10-26)
- Completion: 2023-06-30 (anticipated) (ClinicalTrials.gov record NCT04524624, source copy `cardio:ctgov-nct04524624-2020-08-24`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04524624, source copy `cardio:ctgov-nct04524624-2020-08-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04524624-2020-08-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: An AI-Based CDSS for Integrated Management of Patients With Acute Ischemic Stroke(GOLDEN BRIDGE II)
- Condition: Stroke
- Intervention (Device): AI-based CDSS
- Lead sponsor: Beijing Tiantan Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Beijing Tiantan Hospital (`cardio:org-beijing-tiantan-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of a clinical decision support system on stroke care quality and outcomes in patients with acute ischaemic stroke (GOLDEN BRIDGE II): cluster randomised clinical trial (`cardio:pubmed-41862204`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: d5ff63fe359dc60aeab41de863e58f23b2bc44c189e3fe15a56fcb5719674546
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
